AzTrials
AzTrials

Dentine HypersensitivityNCT07647861

Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine Hypersensitivity

A study testing Nd:YAG Laser Application, Diode Laser Application and Herbal Propolis-Based Dentin Barrier Agent in people with Dentine Hypersensitivity, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dentine hypersensitivity is a common clinical problem. Although Nd:YAG lasers, diode lasers, and topical desensitizing agents are widely utilized, long-term comparative evidence regarding their clinical efficacy remains limited. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Dentine Hypersensitivity
What is being tested?
Nd:YAG Laser Application, Diode Laser Application and Herbal Propolis-Based Dentin Barrier Agent
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
140 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Dec 2025to 10 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged between 18 and 65 years.
  • Presence of at least two hypersensitive teeth.
  • Visual Analog Scale (VAS) score of 4 or higher (VAS >= 4) following stimulus.
  • Schiff Cold Air Sensitivity Scale score of 2 or higher (Schiff >= 2).
  • Presence of vital teeth in the target area.
  • Patient is willing and able to provide written informed consent prior to study initiation.

Who cannot join

  • Pregnancy or lactation.
  • Presence of active periodontal disease in the target area.
  • Teeth with dental caries, deep restorations, or cracked tooth syndrome.
  • Endodontically treated teeth.
  • History of allergy or hypersensitivity related to the materials, products, or chemical agents used in the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ondokuz Mayıs University, Faculty of Dentistry, Department of Periodontology

    Samsun, Samsun, 55270

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Nd:YAG Laser, Diode Laser, Herbal Propolis-Based Dentin Barrier Agent, and Sham Application in the Treatment of Dentine Hypersensitivity: A Randomized Controlled Clinical Trial

Dentine hypersensitivity is a common clinical problem. Although Nd:YAG lasers, diode lasers, and topical desensitizing agents are widely utilized, long-term comparative evidence regarding their clinical efficacy remains limited. This prospective, randomized, parallel-arm, evaluator-blind, sham-controlled clinical trial evaluated and compared the 12-month clinical performance of an Nd:YAG laser, a diode laser, a herbal propolis-based dentin barrier agent, and a sham application.

Read the detailed description

This study was conducted as a prospective, randomized, parallel-arm, evaluator-blinded, sham-controlled clinical trial to evaluate and compare the clinical efficacy of four different treatment modalities for dentine hypersensitivity over a 6-month follow-up period.

A total of 140 patients who met the eligibility criteria were enrolled and randomly allocated into four equal groups (n=35 per group) using a block randomization method with a 1:1:1:1 allocation ratio. The intervention groups were assigned as follows:

Group 1 received Nd:YAG laser application.

Group 2 received Diode laser application.

Group 3 received a topical application of a herbal propolis-based dentin barrier agent.

Group 4 received a sham (placebo) application to simulate the treatment experience without delivering any active laser or therapeutic agent benefits.

Clinical evaluations were performed at baseline, immediately post-treatment, 1 week, 1 month, 3 months, and 6 months. The primary outcome was the change in pain intensity measured by the Visual Analog Scale (VAS) following a controlled air blast stimulus from baseline to 6 months. Secondary outcomes included changes in the Schiff Cold Air Sensitivity Scale, tactile sensitivity scores, patient satisfaction levels, the documentation of any adverse events, and the need for additional treatment during the 6-month period. To ensure objectivity, all clinical assessments and statistical analyses were performed by researchers who were fully blinded to the treatment allocations.

Being tested
Nd:YAG Laser Application, Diode Laser Application, Herbal Propolis-Based Dentin Barrier Agent, Sham Application
Keywords
Dentine Hypersensitivity, Nd:YAG Laser, Diode Laser, Propolis, Lasers in Dentistry, Dentin Desensitizing Agents
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nd:YAG Laser ApplicationDevice

    Nd:YAG laser application performed for the treatment of dentine hypersensitivity.

  • Diode Laser ApplicationDevice

    Diode laser application performed for the treatment of dentine hypersensitivity.

  • Herbal Propolis-Based Dentin Barrier AgentOther

    Topical application of a herbal propolis-based dentin barrier agent.

  • Sham ApplicationOther

    Placebo/sham procedure to simulate treatment without delivering active laser or therapeutic agent benefits

Study groups in NCT07647861
Study groupRoleWhat they receive
Group 1: Nd:YAG LaserExperimentalParticipants assigned to this group received Nd:YAG laser application targeted at the hypersensitive teeth to achieve desensitization. The procedure was completed during the treatment session according to the clinical protocol.
Receives: Device: Nd:YAG Laser Application
Group 2: Diode LaserExperimentalParticipants assigned to this group received Diode laser application on the affected dentine areas for hypersensitivity treatment. The application was performed in accordance with the specified parameters.
Receives: Device: Diode Laser Application
Group 3: Dentin Barrier AgentExperimentalParticipants assigned to this group received a topical application of a herbal propolis-based dentin barrier agent onto the hypersensitive tooth surfaces. The agent was applied to seal the dentinal tubules and reduce sensitivity.
Receives: Other: Herbal Propolis-Based Dentin Barrier Agent
Group 4: Sham ApplicationSham comparatorParticipants assigned to this group received a sham (placebo) procedure designed to completely simulate the laser or topical application experience without delivering any active laser energy or therapeutic desensitizing agent. This group served as the control to account for the placebo effect.
Receives: Other: Sham Application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Visual Analog Scale (VAS) Score after Air Stimulus

    Pain intensity evaluated using the Visual Analog Scale (VAS), where scores range from 0 (no pain) to 10 (extreme/worst pain). The primary outcome is defined as the change in pain intensity in response to a controlled air blast stimulus from baseline to 6 months.

    Measured: Baseline and 6 months

Secondary outcomes (2)
  1. Schiff Cold Air Sensitivity Scale Score

    Dentine sensitivity assessed using the Schiff Cold Air Sensitivity Scale, where scores range from 0 (patient does not respond to air stimulus) to 3 (patient responds to air stimulus, experiences pain, and requests discontinuation of stimulus).

    Measured: Baseline, immediately post-treatment, 1 week, 1 month, 3 months, and 6 months

  2. Tactile Sensitivity Score

    Tactile sensitivity evaluated using a standard dental explorer probe passed across the affected dentine surface to record the presence or absence of discomfort or pain.

    Measured: Baseline, immediately post-treatment, 1 week, 1 month, 3 months, and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2026
  2. Study start15 Dec 2025
  3. Primary completion10 Jun 2026
  4. Study completion10 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized, parallel-group, evaluator-blinded, sham-controlled clinical trial with four allocation arms. Eligible participants were randomly assigned to one of the four groups in a 1:1:1:1 ratio to receive a single type of intervention (Nd:YAG laser, Diode laser, herbal propolis-based dentin barrier agent, or sham application) and were followed up for a period of 6 months.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07647861
Sponsor's protocol ID
2025000326-2
Status last verified
Jun 2026
First submitted
10 Jun 2026
Last updated
15 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly to ensure patient confidentiality and compliance with the ethical committee approval, which did not include a provision for public data repository sharing.

Questions about this trial

What is this clinical trial studying?

A study testing Nd:YAG Laser Application, Diode Laser Application and Herbal Propolis-Based Dentin Barrier Agent in people with Dentine Hypersensitivity, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Visual Analog Scale (VAS) Score after Air Stimulus (time frame: Baseline and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in